Nureca has informed it enclosed disclosure received from Nectar Biopharma, Member of Promoter Group pursuant to Regulation 7(2) of PIT Regulations in respect of disposal of shares of the company through an off-market transaction. The disclosure is not required vide SEBI Circular No. SEBI/HO/ISD/ISD/CIR/P/2020/168 and SEBI/HO/ISD/ISD/CIR/P/2021/617 dated September 09, 2020 and August 13, 2021 respectively.
The above information is a part of company’s filings submitted to BSE.